Quantitative Assessment of Human T Lymphocytes in RAG2-/-γc-/- Mice: The Impact of Ex Vivo Manipulation on In Vivo Functionality

Experimental Hematology

Volumn 35, Issue 1, 2007, Pages 117-127

  van Rijn, Rozemarijn S ^a   Simonetti, Elles R ^a   Hagenbeek, Anton ^a   Bonyhadi, Mark ^b   Storm, Gert ^c   Martens, Anton C M ^a   Ebeling, Saskia B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CYCLACEL LTD   (United Kingdom)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL POPULATION; CELL STIMULATION; EFFECTOR CELL; ENGRAFTMENT; EX VIVO STUDY; FEASIBILITY STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MEMORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SURVIVAL; T LYMPHOCYTE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DNA-BINDING PROTEINS; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE TRANSFUSION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 33845788763     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.09.018     Document Type: Article

References (45)

1. Marktel S., Magnani Z., Ciceri F., et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101 (2003) 1290-1298
2. Rosenberg S.A., and Dudley M.E. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci U S A 101 Suppl 2 (2004) 14639-14645
3. Tiberghien P., Ferrand C., Lioure B., et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97 (2001) 63-72
4. Sauce D., Bodinier M., Garin M., et al. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 99 (2002) 1165-1173
5. Weijtens M., van S.A., Hagenbeek A., Braakman E., and Martens A. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Hum Gene Ther 13 (2002) 187-198
6. Drobyski W.R., Majewski D., Ozker K., and Hanson G. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. J Immunol 161 (1998) 2610-2619
7. Ferrand C., Robinet E., Contassot E., et al. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor β chain hypervariable region repertoire. Hum Gene Ther 11 (2000) 1151-1164
8. Noel P.J., Boise L.H., Green J.M., and Thompson C.B. CD28 costimulation prevents cell death during primary T cell activation. J Immunol 157 (1996) 636-642
9. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 (2002) 116-126
10. Wolf H., Muller Y., Salmen S., Wilmanns W., and Jung G. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur J Immunol 24 (1994) 1410-1417
11. Orchard P.J., Blazar B.R., Burger S., et al. Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor. Hum Gene Ther 13 (2002) 979-988
12. Radvanyi L.G., Shi Y., Vaziri H., et al. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol 156 (1996) 1788-1798
13. DeBenedette M.A., Shahinian A., Mak T.W., and Watts T.H. Costimulation of CD28-T lymphocytes by 4-1BB ligard. J Immunol 158 (1997) 551-559
14. Kwon B.S., and Weissman S.M. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A 86 (1989) 1963-1967
15. Pollok K.E., Kim Y.J., Hurtado J., et al. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 24 (1994) 367-374
16. DeBenedette M.A., Wen T., Bachmann M.F., et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 163 (1999) 4833-4841
17. Hurtado J.C., Kim Y.J., and Kwon B.S. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 158 (1997) 2600-2609
18. Takahashi C., Mittler R.S., and Vella A.T. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 162 (1999) 5037-5040
19. Tan J.T., Whitmire J.K., Ahmed R., Pearson T.C., and Larsen C.P. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 163 (1999) 4859-4868
20. Tan J.T., Whitmire J.K., Murali-Krishna K., et al. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol 164 (2000) 2320-2325
21. Hesselton R.M., Koup R.A., Cromwell M.A., et al. Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. J Infect Dis 168 (1993) 630-640
22. Mosier D.E., Gulizia R.J., Baird S.M., and Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335 (1988) 256-259
23. Tary-Lehmann M., and Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med 175 (1992) 503-516
24. Tary-Lehmann M., Saxon A., and Lehmann P.V. The human immune system in hu-PBL-SCID mice. Immunol Today 16 (1995) 529-533
25. -/- double-mutant mice. Blood 102 (2003) 2522-2531
26. Maus M.V., Thomas A.K., Leonard D.G.B., et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat Biotechnol 20 (2002) 143-148
27. Bhattacharya A., Dorf M.E., and Springer T.A. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol 127 (1981) 2488-2495
28. Murphy W.J., Conlon K.C., Sayers T.J., et al. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J Immunol 150 (1993) 3634-3642
29. Hoffmann-Fezer G., Gall C., Zengerle U., Kranz B., and Thierfelder S. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in Scid mice. Blood 81 (1993) 3440-3448
30. Hendriks J., Gravestein L.A., Tesselaar K., et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1 (2000) 433-440
31. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
32. + T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 180 (1994) 1817-1827
33. Garcia S., Dadaglio G., and Gougeon M.L. Limits of the human-PBL-SCID mice model: severe restriction of the V β T-cell repertoire of engrafted human T cells. Blood 89 (1997) 329-336
34. Pflumio F., Lapidot T., Murdoch B., Patterson B., and Dick J.E. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 5 (1993) 1509-1522
35. Murphy W.J., Bennett M., Anver M.R., Baseler M., and Longo D.L. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 22 (1992) 1421-1427
36. + T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104 (2004) 1565-1573
37. Cooke K.R., Kobzik L., Martin T.R., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88 (1996) 3230-3239
38. Contassot E., Murphy W., Angonin R., et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation 65 (1998) 1365-1370
39. + T cells. J Clin Invest 115 (2005) 1616-1626
40. Mesel-Lemoine M., Cherai M., Le G.S., et al. Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy. Blood 107 (2006) 381-388
41. Imai C., Iwamoto S., and Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106 (2005) 376-383
42. Melero I., Johnston J.V., Shufford W.W., Mittler R.S., and Chen L. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol 190 (1998) 167-172
43. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
44. Ye Z., Hellstrom I., Hayden-Ledbetter M., et al. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat Med 8 (2002) 343-348
45. Mosier D.E., Gulizia R.J., MacIsaac P.D., Corey L., and Greenberg P.D. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci U S A 90 (1993) 2443-2447